Janet Hammond
Chief Medical Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Atea Pharmaceuticals, Inc. (AVIR) | MD, PhD Chief Development Officer | $590,892 | $1,767,234 |
| 2024 | Atea Pharmaceuticals, Inc. (AVIR) | MD, PhD Chief Development Officer | $573,682 | $2,159,031 |
| 2023 | Atea Pharmaceuticals, Inc. (AVIR) | MD, PhD Chief Development Officer | $556,973 | $2,107,297 |
| 2022 | Atea Pharmaceuticals, Inc. (AVIR) | MD, PhD Chief Development Officer | $530,450 | $2,112,151 |
| 2021 | Atea Pharmaceuticals, Inc. (AVIR) | M.D., Ph.D. Chief Development Officer | $515,000 | $9,007,023 |
| 2020 | Atea Pharmaceuticals, Inc. (AVIR) | M.D., Ph.D. Chief Development Officer | $197,115 | $4,030,318 |
Earnings-call appearances
-
Atea Pharmaceuticals, Inc. Q1 FY2026 Earnings Call2026-05-12
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q4 FY2025 Earnings Call2026-03-05
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q4 FY2024 Earnings Call2025-01-14
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q3 FY2024 Earnings Call2024-11-07
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q2 FY2024 Earnings Call2024-08-07
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q1 FY2024 Earnings Call2024-05-14
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q4 FY2023 Earnings Call2024-02-28
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q3 FY2023 Earnings Call2023-11-08
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q2 FY2023 Earnings Call2023-08-08
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q1 FY2023 Earnings Call2023-05-08
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q4 FY2022 Earnings Call2023-02-28
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q3 FY2022 Earnings Call2022-11-07
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q2 FY2022 Earnings Call2022-08-08
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q1 FY2022 Earnings Call2022-05-10
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q4 FY2021 Earnings Call2022-02-28
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q3 FY2021 Earnings Call2021-11-12
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q2 FY2021 Earnings Call2021-08-12
Atea Pharmaceuticals, Inc. (AVIR)
-
Atea Pharmaceuticals, Inc. Q1 FY2021 Earnings Call2021-05-13
Atea Pharmaceuticals, Inc. (AVIR)